TY - JOUR
T1 - Hypothalamic-pituitary-adrenal axis dysfunction in critically ill patients with traumatic brain injury
T2 - Incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels
AU - Dimopoulou, Ioanna
AU - Tsagarakis, Stylianos
AU - Kouyialis, Andreas T.
AU - Roussou, Paraskevi
AU - Assithianakis, Georgios
AU - Christoforaki, Marietta
AU - Ilias, Ioannis
AU - Sakas, Damianos E.
AU - Thalassinos, Nikolaos
AU - Roussos, Charis
PY - 2004/2
Y1 - 2004/2
N2 - Objective: To investigate hypothalamic-pituitary-adrenal axis function in patients requiring mechanical ventilation for traumatic brain injury and to assess the relation of hypothalamic-pituitary-adrenal axis abnormalities with vasopressor dependence and peripheral cytokine levels. Design: Prospective study. Setting: General intensive care unit in a university teaching hospital. Patients: Forty patients (33 men and 7 women) with moderate to severe traumatic brain injury (mean age, 37 ± 16 yrs) were studied the day after termination of mechanical ventilation (7-60 days after trauma). Interventions: First, a morning blood sample was obtained to measure baseline cortisol, corticotropin, interleukin-6, and tumor necrosis factor alpha. Subsequently, 1 μg of synthetic corticotropin was injected intravenously, and 30 mins later, a second blood sample was drawn to determine stimulated plasma cortisol. Based on data derived from healthy volunteers, patients having stimulated cortisol levels <18 μg/dL were defined as nonresponders to the low-dose stimulation test. Thirty-one patients underwent also a human corticotropin releasing hormone test. Measurements and Main Results: In traumatic brain injury patients, mean baseline and low-dose stimulation test-stimulated cortisol levels were 17.2 ± 5.4 μg/dL and 24.0 ± 6.6 μg/dL, respectively. The median increment in cortisol was 5.9 μg/dL. Basal corticotropin levels ranged from 3.9 to 118.5 pg/mL. Six of the 40 patients (15%) failed the low-dose stimulation test. The human corticotropin releasing hormone test (performed in 26 responders and five nonresponders) revealed diminished cortisol release only in the low-dose stimulation test nonresponder patients. Corticotropin responses to corticotropin releasing hormone were consistent with both primary (three patients) and/or secondary (two patients) adrenal dysfunction. In retrospect, nonresponders to the low-dose stimulation test more frequently required vasopressors (6/6 [100%] vs. 16/34 [47%]; p = .02) and for a longer time interval (median, 0 vs. 293 hrs; p = .006) compared with responders. Furthermore, nonresponders had higher interleukin-6 levels compared with responders (56.03 vs. 28.04 pg/mL; p = .01), whereas tumor necrosis factor alpha concentrations were similar in the two groups (2.42 vs. 1.55 pg/mL; p = .53). Conclusions: Adrenal cortisol secretion after dynamic stimulation is deficient in a subset of critically ill patients with moderate to severe head injury. This disorder is associated with prior vasopressor dependency and higher interleukin-6 levels.
AB - Objective: To investigate hypothalamic-pituitary-adrenal axis function in patients requiring mechanical ventilation for traumatic brain injury and to assess the relation of hypothalamic-pituitary-adrenal axis abnormalities with vasopressor dependence and peripheral cytokine levels. Design: Prospective study. Setting: General intensive care unit in a university teaching hospital. Patients: Forty patients (33 men and 7 women) with moderate to severe traumatic brain injury (mean age, 37 ± 16 yrs) were studied the day after termination of mechanical ventilation (7-60 days after trauma). Interventions: First, a morning blood sample was obtained to measure baseline cortisol, corticotropin, interleukin-6, and tumor necrosis factor alpha. Subsequently, 1 μg of synthetic corticotropin was injected intravenously, and 30 mins later, a second blood sample was drawn to determine stimulated plasma cortisol. Based on data derived from healthy volunteers, patients having stimulated cortisol levels <18 μg/dL were defined as nonresponders to the low-dose stimulation test. Thirty-one patients underwent also a human corticotropin releasing hormone test. Measurements and Main Results: In traumatic brain injury patients, mean baseline and low-dose stimulation test-stimulated cortisol levels were 17.2 ± 5.4 μg/dL and 24.0 ± 6.6 μg/dL, respectively. The median increment in cortisol was 5.9 μg/dL. Basal corticotropin levels ranged from 3.9 to 118.5 pg/mL. Six of the 40 patients (15%) failed the low-dose stimulation test. The human corticotropin releasing hormone test (performed in 26 responders and five nonresponders) revealed diminished cortisol release only in the low-dose stimulation test nonresponder patients. Corticotropin responses to corticotropin releasing hormone were consistent with both primary (three patients) and/or secondary (two patients) adrenal dysfunction. In retrospect, nonresponders to the low-dose stimulation test more frequently required vasopressors (6/6 [100%] vs. 16/34 [47%]; p = .02) and for a longer time interval (median, 0 vs. 293 hrs; p = .006) compared with responders. Furthermore, nonresponders had higher interleukin-6 levels compared with responders (56.03 vs. 28.04 pg/mL; p = .01), whereas tumor necrosis factor alpha concentrations were similar in the two groups (2.42 vs. 1.55 pg/mL; p = .53). Conclusions: Adrenal cortisol secretion after dynamic stimulation is deficient in a subset of critically ill patients with moderate to severe head injury. This disorder is associated with prior vasopressor dependency and higher interleukin-6 levels.
KW - Human corticotropin releasing hormone test
KW - Interleukin-6
KW - Low-dose corticotropin stimulation test
KW - Primary adrenal dysfunction
KW - Traumatic brain injury
UR - http://www.scopus.com/inward/record.url?scp=10744229139&partnerID=8YFLogxK
U2 - 10.1097/01.CCM.0000108885.37811.CA
DO - 10.1097/01.CCM.0000108885.37811.CA
M3 - Article
C2 - 14758155
AN - SCOPUS:10744229139
SN - 0090-3493
VL - 32
SP - 404
EP - 408
JO - Critical Care Medicine
JF - Critical Care Medicine
IS - 2
ER -